scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1104562242 |
P356 | DOI | 10.1186/S40425-018-0350-X |
P932 | PMC publication ID | 6000980 |
P698 | PubMed publication ID | 29898782 |
P50 | author | Kerry D Fisher | Q58227976 |
Len Seymour | Q60020655 | ||
Egon J Jacobus | Q61093626 | ||
P2093 | author name string | Silvio Hemmi | |
Alice Brown | |||
Janet Lei | |||
Margaret R Duffy | |||
Brian Champion | |||
William K Taverner | |||
Fred Lilley | |||
Lorna Slater | |||
Katy West | |||
P2860 | cites work | The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction | Q24291966 |
The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses. | Q24522973 | ||
Translation by ribosome shunting on adenovirus and hsp70 mRNAs facilitated by complementarity to 18S rRNA | Q24609345 | ||
Structure of the Extracellular Portion of CD46 Provides Insights into Its Interactions with Complement Proteins and Pathogens | Q27664992 | ||
Selective translation initiation by ribosome jumping in adenovirus-infected and heat-shocked cells | Q28282385 | ||
The human membrane cofactor CD46 is a receptor for species B adenovirus serotype 3 | Q33201422 | ||
Directed evolution generates a novel oncolytic virus for the treatment of colon cancer | Q33344440 | ||
Role of cellular heparan sulfate proteoglycans in infection of human adenovirus serotype 3 and 35. | Q33381618 | ||
Preclinical Safety Studies of Enadenotucirev, a Chimeric Group B Human-Specific Oncolytic Adenovirus | Q33633287 | ||
Going viral with cancer immunotherapy | Q34427647 | ||
Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14. | Q34781681 | ||
Avidity binding of human adenovirus serotypes 3 and 7 to the membrane cofactor CD46 triggers infection | Q35689715 | ||
SEC14L2 enables pan-genotype HCV replication in cell culture | Q35743753 | ||
Mouse adenovirus type 1 causes a fatal hemorrhagic encephalomyelitis in adult C57BL/6 but not BALB/c mice | Q35852023 | ||
Immunocompetent syngeneic cotton rat tumor models for the assessment of replication-competent oncolytic adenovirus | Q36184357 | ||
Failure of translation of human adenovirus mRNA in murine cancer cells can be partially overcome by L4-100K expression in vitro and in vivo. | Q36220647 | ||
Oncolytic Group B Adenovirus Enadenotucirev Mediates Non-apoptotic Cell Death with Membrane Disruption and Release of Inflammatory Mediators. | Q36323413 | ||
Development of a versatile oncolytic virus platform for local intra-tumoural expression of therapeutic transgenes. | Q36380295 | ||
Actin-resistant DNAse I Expression From Oncolytic Adenovirus Enadenotucirev Enhances Its Intratumoral Spread and Reduces Tumor Growth | Q36951268 | ||
Oncolytic virotherapy | Q38025263 | ||
Oncolytic virotherapy and immunogenic cancer cell death: sharpening the sword for improved cancer treatment strategies | Q38139255 | ||
Group B adenovirus enadenotucirev infects polarised colorectal cancer cells efficiently from the basolateral surface expected to be encountered during intravenous delivery to treat disseminated cancer. | Q38713629 | ||
Oncolytic viruses-immunotherapeutics on the rise | Q38919107 | ||
A mouse mammary epithelial cell line permissive for highly efficient human adenovirus growth | Q39241643 | ||
Productive replication of human adenoviruses in mouse epidermal cells | Q39589975 | ||
Comparative sequence analysis of the largest E1A proteins of human and simian adenoviruses | Q39753100 | ||
Oncolytic adenovirus expressing bispecific antibody targets T-cell cytotoxicity in cancer biopsies | Q40152125 | ||
Evaluation of adenovirus vectors containing serotype 35 fibers for tumor targeting | Q40250421 | ||
Syrian hamster as a permissive immunocompetent animal model for the study of oncolytic adenovirus vectors. | Q40322147 | ||
Regulation of translation by ribosome shunting through phosphotyrosine-dependent coupling of adenovirus protein 100k to viral mRNAs | Q40435988 | ||
Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection. | Q41706961 | ||
Activity of a group B oncolytic adenovirus (ColoAd1) in whole human blood. | Q42236177 | ||
Molecular biology of adenovirus type 2 semipermissive infections. I. Viral growth and expression of viral replicative functions during restricted adenovirus infection | Q42812969 | ||
Novel immunocompetent murine tumor models for the assessment of replication-competent oncolytic adenovirus efficacy. | Q44729128 | ||
CD46 is a cellular receptor for group B adenoviruses | Q45869560 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | immunology | Q101929 |
Adenoviridae | Q193447 | ||
pharmacology | Q128406 | ||
oncolytic virus | Q1560099 | ||
cancer research | Q3421914 | ||
molecular medicine | Q3523816 | ||
P304 | page(s) | 55 | |
P577 | publication date | 2018-06-13 | |
P1433 | published in | Journal for Immunotherapy of Cancer | Q27725163 |
P1476 | title | Expression of human CD46 and trans-complementation by murine adenovirus 1 fails to allow productive infection by a group B oncolytic adenovirus in murine cancer cells. | |
P478 | volume | 6 |
Q90736824 | External Beam Radiation Therapy and Enadenotucirev: Inhibition of the DDR and Mechanisms of Radiation-Mediated Virus Increase | cites work | P2860 |
Search more.